Advertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense. Effective date. Emergency.

SB 771 prohibits Oklahoma pharmaceutical companies from advertising prescription drugs directly to consumers through any medium (TV, digital, print, social media, etc.). Violating this ban would be a felony punishable by up to $500,000 in fines or five years in prison per offense. The bill includes exceptions for doctor-patient educational materials, public health campaigns, clinical trial promotions, and insurance coverage information - provided they don’t promote specific drugs. It takes effect July 1, 2025, and aims to align Oklahoma with global norms that restrict such advertising.